Table II.
Associations of SPHK1 expression with the clinicopathological features of patients with ESCC.
Features | n | SPHK1 expression
|
χ2 | P-value | |
---|---|---|---|---|---|
+ | − | ||||
Sex | 0.526 | 0.468 | |||
Male | 55 | 32 | 23 | ||
Female | 30 | 15 | 15 | ||
Age, years | 1.746 | 0.186 | |||
<60 | 38 | 18 | 20 | ||
≥60 | 47 | 29 | 18 | ||
Smoking | 0.337 | 0.562 | |||
Yes | 41 | 24 | 17 | ||
No | 44 | 23 | 21 | ||
Drinking | 1.646 | 0.200 | |||
Yes | 49 | 30 | 19 | ||
No | 36 | 17 | 19 | ||
Tumor diameter, cm | 2.031 | 0.154 | |||
<4 | 51 | 25 | 26 | ||
≥4 | 34 | 22 | 12 | ||
Differentiation degree | 0.616 | 0.433 | |||
High/moderate | 52 | 27 | 25 | ||
Poor | 33 | 20 | 13 | ||
Tumor-Node-Metastases stage | 8.567 | 0.003a | |||
I-II | 55 | 24 | 31 | ||
III-IV | 30 | 23 | 7 | ||
Lymph node metastasis | 6.559 | 0.010a | |||
Yes | 28 | 21 | 7 | ||
No | 57 | 26 | 31 |
P≤0.01.